pharmaphorum

DECEMBER 22, 2022

AstraZeneca’s (AZ) Imfinzi (durvalumab) has been approved in the European Union (EU) as first-line treatment of adult patients with unresectable or metastatic biliary tract cancer (BTC) in combination with chemotherapy (gemcitabine plus cisplatin). with chemotherapy. Updated median overall survival (OS) was 12.9 months versus 11.3

Chemotherapy 63

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 63

Pharmafile

APRIL 24, 2023

Published date: 21/04/2023 Summary: Approval for AKEEGA® is based on results from the Phase 3 MAGNITUDE study, a prospectively designed precision medicine study that includes the largest cohort to date of BRCA1/2-positive patients with untreated metastatic castration-resistant prostate cancer (mCRPC). 2 read more

Chemotherapy 40

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 40

Hospital Pharmacy Europe

JUNE 9, 2023

For example, it suggested that when secondary care has access to the electronic prescribing system, the dispensing of drugs currently dispensed by NHS trusts – including high-tech medicines such as oral chemotherapy or immunotherapy drugs and monoclonal antibody therapies – could be moved to community pharmacy.

Community Pharmacies 98

Community Pharmacies Hospitals Chemotherapy Pharmaceutical Companies 98

Pharmaceutical Technology

FEBRUARY 24, 2023

ACD-440 overview ACD-440 is under development for the treatment of neuropathic pain including painful peripheral polyneuropathy, peripheral mononeuropathy, postherpetic neuralgia (PHN), chemotherapy induced neuropathic pain, nerve injury pain, chronic postoperative neuropathic pain and peripheral neuropathic pain.

Chemotherapy 40

Chemotherapy Compounding Pharmaceutical Companies Pharmaceutical Companies 40

pharmaphorum

JUNE 8, 2021

At the same time, lots of people with experience at multinational pharmaceutical companies have chosen to return home. All these factors will support the growth of in-house R&D-driven pharmaceutical companies and bring more innovative drugs to Asian markets.”. Chemotherapy still accounted for 72.6%

Chemotherapy 105

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies Immunization 105

Pharmaceutical Technology

AUGUST 1, 2022

If left unchecked, it may soon not be possible to use antibiotics as prophylaxis for immunocompromised patients during chemotherapy or organ transplants. If robust support comes from governments, pharma companies will grow in confidence about entering this area, and hopefully, a much-needed flurry of antibiotics will be developed.

Vaccines 93

Vaccines Pharmaceutical Companies Pharmaceutical Companies Chemotherapy 93

Roots Analysis

DECEMBER 11, 2022

Antibody drug conjugates (ADCs) are an upcoming class of targeted therapeutic agents that have garnered the attention of pharmaceutical companies, and academic / research institutions across the world.

Chemotherapy 40

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 40

pharmaphorum

NOVEMBER 24, 2020

Because of the lockdown, it is not surprising, but very worrying, that cancer specialists reported delays in diagnoses, surgeries and chemotherapy during each of the three waves of interviews. Pharmaceutical companies cannot address this challenge alone. This pattern was seen across the five countries.

Pharmaceutical Companies 80

Pharmaceutical Companies Pharmaceutical Companies Vaccines Chemotherapy 80

Viseven

OCTOBER 31, 2023

The journey that followed—filled with the courses of chemotherapy, surgeries, and radiation—tested me in ways I could never have imagined. Nataliya is convinced that pharmaceutical companies should approach each patient as an individual with unique circumstances and distinct needs. What fortified me during those trying times?

Chemotherapy 52

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies Communication 52

European Pharmaceutical Review

DECEMBER 12, 2023

Pharmaceutical companies such as Sanofi and AstraZeneca are currently conducting several high-potential clinical development programmes in oncology in collaboration with Innate Pharma. Innate Pharma has also partnered with Takeda to develop an antibody drug conjugate (ADC).

Immunization 103

Immunization Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 103

Hospital Pharmacy Europe

AUGUST 17, 2023

GoCART aims to promote patient access to novel cellular therapies, bringing together different stakeholders, including healthcare professionals, health authorities, pharmaceutical companies, patient representatives, health technology assessment bodies, reimbursement agencies and medical non-profit organisations.

Hospitals 98

Hospitals Documentation Chemotherapy Pharmaceutical Companies 98

pharmaphorum

JANUARY 5, 2022

However, these patients generally receive chemotherapy with Sanofi’s Jevtana (cabazitaxel) or docetaxel, or Bayer’s radiopharma drug Xofigo (radium233-dichloride). The post After a Scottish aye, NICE says no to Lynparza for prostate cancer appeared first on.

Chemotherapy 52

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JANUARY 27, 2022

” Additionally, pharma can use VR for monitoring brain health during treatments, such as chemotherapy. . “Those struggling with addiction, for example, might not be able or willing to attend an in-person meeting because of concerns about job security or community reactions. VR can be a useful venue for them.”

Chemotherapy 142

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 142

Roots Analysis

OCTOBER 24, 2023

Hence, they are commonly used in the treatment of cancer, as part of the chemotherapy regime. However, owing to the several challenges associated with HPAPI manufacturing, majority of the pharmaceutical companies prefer to outsource their manufacturing operations. They can also inhibit or prevent the function of cells.

Compounding 40

Compounding Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 40

pharmaphorum

SEPTEMBER 29, 2020

One powerful example is The National Institutes of Health’s Partnership for Accelerating Cancer Therapies (PACT) , which brought together 11 pharmaceutical companies to accelerate the development of new cancer immunotherapies.

Chemotherapy 132

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 132

PharmaShots

MARCH 29, 2023

Shots: Drug patent expiry is when a patent granted to a pharmaceutical company for a particular drug expires, allowing other companies to produce and sell generic versions Like every other utility patent, pharmaceuticals also get market exclusivity of 20 years.

FDA 49

FDA Chemotherapy Immunization Dosage 49

ISPE

NOVEMBER 1, 2022

Thomas Wozniewski, Global Manufacturing and Supply Officer at Takeda Pharmaceutical Company Ltd, presented on “Future-proofing a Global TechOps Organization: The Transformation of Global Manufacturing and Supply at Takeda.”. Next Slide ??. Michael Kopcha. Thomas Wozniewski. Robert Weker. Transforming Global Manufacturing and Supply.

FDA 98

FDA Insurance Chemotherapy Documentation 98

European Pharmaceutical Review

APRIL 10, 2024

4 Notably, microbiome therapies have strong potential in onco-haematology, where antibiotic and chemotherapy-derived loss of gut diversity is predictive of mortality in patients who have undergone an allogeneic haematopoietic stem cell transplant, as well as GvHD occurrence and infection. eClinicalMedicine. 2023; 62:102111.

Immunization 81

Immunization Chemotherapy FDA Pharmaceutical Companies 81

pharmaphorum

OCTOBER 3, 2022

The Life Sciences Practice works with leading biotech, medical device, and pharmaceutical companies; law firms; regulatory agencies; and national and international industry associations. Single Technology Appraisal: Sugemalimab with chemotherapy for untreated metastatic non-small-cell lung cancer ID4001. Dec 2021.

Chemotherapy 98

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies FDA 98

pharmaphorum

SEPTEMBER 4, 2020

Traditionally, cancer patients are treated using “one size fits all” interventions like chemotherapy, radiotherapy and surgery. To deliver these unique therapies to patients, pharmaceutical companies must partner with a wide range of specialized third parties including laboratories, manufacturers, shipping and storing providers.

Communication 55

Communication Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 55

Pharmaceutical Technology

JULY 23, 2008

The world’s biggest pharmaceutical company Pfizer announced in June 2008 that it would be putting its “full scope and scale” behind a push into the cancer market. “Companies used to be universally protected by patents but there is a pathway to approval opening up for biosimilar legislation. .

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Compounding Chemotherapy 52

Pharmaceutical Technology

FEBRUARY 17, 2023

However, Amgen and other pharmaceutical companies have been criticised when they opted to choose the drug’s dosage based on the MTD model, which is commonly used in dose-finding trials. Impact on the industry Veal says that for a lot of pharmaceutical companies there is no “big drive to think about optimizing treatment” post-licensing.

Dosage 115

Dosage FDA Pharmaceutical Companies Pharmaceutical Companies 115

Pharmaceutical Technology

JUNE 16, 2023

Designated as BG01-2202, this latest trial will be an open-label, randomised, controlled clinical study of UTD1 versus chemotherapy drug docetaxel. A Phase III study to evaluate UTD1 versus docetaxel in patients that have failed chemotherapy with a platinum-containing regimen is also currently underway in China. ORR, 81.0%

FDA 52

FDA Chemotherapy Labelling Pharmaceutical Companies 52